111 Total Assets 2018-2024 | YI
111 total assets from 2018 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
| 111 Annual Total Assets (Millions of US $) |
|
|---|---|
| 2024 | $382 |
| 2023 | $435 |
| 2022 | $504 |
| 2021 | $494 |
| 2020 | $464 |
| 2019 | $231 |
| 2018 | $225 |
| 2017 | $115 |
| 111 Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2024-12-31 | $382 |
| 2024-09-30 | $432 |
| 2024-06-30 | $384 |
| 2024-03-31 | $405 |
| 2023-12-31 | $435 |
| 2023-09-30 | $461 |
| 2023-06-30 | $421 |
| 2023-03-31 | $472 |
| 2022-12-31 | $504 |
| 2022-09-30 | $429 |
| 2022-06-30 | $463 |
| 2022-03-31 | $475 |
| 2021-12-31 | $494 |
| 2021-09-30 | $486 |
| 2021-06-30 | $511 |
| 2021-03-31 | $470 |
| 2020-12-31 | $464 |
| 2020-09-30 | $401 |
| 2020-06-30 | $267 |
| 2020-03-31 | $233 |
| 2019-12-31 | $231 |
| 2019-09-30 | $234 |
| 2019-06-30 | $253 |
| 2019-03-31 | $239 |
| 2018-09-30 | $247 |
| 2017-12-31 | $115 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.064B | $1.973B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.946B | 59.99 |
| Hims & Hers Health (HIMS) | United States | $12.884B | 133.86 |
| Tempus AI (TEM) | United States | $12.253B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.705B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.914B | 61.16 |
| Privia Health (PRVA) | United States | $2.805B | 191.75 |
| Hinge Health (HNGE) | United States | $2.743B | 0.00 |
| Schrodinger (SDGR) | United States | $1.958B | 0.00 |
| Enovis (ENOV) | United States | $1.904B | 10.62 |
| Phreesia (PHR) | United States | $1.677B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.511B | 0.00 |
| Omnicell (OMCL) | United States | $1.424B | 25.12 |
| Azenta (AZTA) | United States | $1.410B | 65.55 |
| 10x Genomics (TXG) | United States | $1.327B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.661B | 0.00 |
| Claritev (CTEV) | United States | $0.646B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.623B | 0.00 |
| Talkspace (TALK) | United States | $0.518B | 154.75 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Standard BioTools (LAB) | United States | $0.410B | 0.00 |
| TruBridge (TBRG) | United States | $0.372B | 824.67 |
| Outset Medical (OM) | United States | $0.362B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.276B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.264B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.200B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| Pulmonx (LUNG) | United States | $0.131B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.112B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.099B | 0.00 |
| CareCloud (CCLD) | United States | $0.095B | 3.61 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.036B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.027B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |